Your browser doesn't support javascript.
loading
Reduced histone H3K4 trimethylation in oral mucosa of patients with DYT-KMT2B.
Sugeno, Naoto; Kumada, Satoko; Kashii, Hirofumi; Ikezawa, Jun; Kawarai, Toshitaka; Nakamura, Takaaki; Miyata, Ako; Ishiyama, Shun; Sato, Kazuki; Yoshida, Shun; Sekiguchi, Hutoshi; Hamanaka, Kohei; Miyatake, Satoko; Miyake, Noriko; Matsumoto, Naomichi; Akagawa, Hiroyuki; Kosaki, Kenjiro; Yoshihashi, Hiroshi; Hasegawa, Takafumi; Aoki, Masashi.
Affiliation
  • Sugeno N; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan. Electronic address: naoto.sugeno.d5@tohoku.ac.jp.
  • Kumada S; Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, Tokyo, 183-0042, Japan.
  • Kashii H; Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, Tokyo, 183-0042, Japan.
  • Ikezawa J; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, 183-0042, Japan.
  • Kawarai T; Department of Clinical Neuroscience, Tokushima University, Tokushima, 770-0042, Japan; Department of Neurology, Harima-Himeji General Medical Center, Himeji, Hyogo, 670-8560, Japan.
  • Nakamura T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
  • Miyata A; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
  • Ishiyama S; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
  • Sato K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
  • Yoshida S; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
  • Sekiguchi H; Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan.
  • Hamanaka K; Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan.
  • Miyatake S; Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan.
  • Miyake N; Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan.
  • Matsumoto N; Department of Clinical Genetics, Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan.
  • Akagawa H; Institute for Comprehensive Medical Sciences, Tokyo Women's Medical University, Tokyo, 162-8666, Japan.
  • Kosaki K; Center for Medical Genetics, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Yoshihashi H; Department of Clinical Genetics, Tokyo Metropolitan Children's Medical Center, Tokyo, 183-8561, Japan.
  • Hasegawa T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan; Department of Neurology, National Health Organization Sendai Nishitaga Hospital, Sendai, Miyagi, 982-8555, Japan.
  • Aoki M; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8574, Japan.
Parkinsonism Relat Disord ; 124: 107018, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38810319
ABSTRACT

BACKGROUND:

DYT-KMT2B, also known as DYT28, is a childhood-onset hereditary dystonia caused by KMT2B mutation. The pathogenesis of DYT-KMT2B involves haploinsufficiency of KMT2B, an enzyme that catalyzes specific histone methylation (H3K4me3). Dysmorphic features in patients with DYT-KMT2B suggest that KMT2B dysfunction may extend beyond the neuronal system. Therefore, valuable diagnostic insights may be obtained from readily available tissue samples.

OBJECTIVES:

To explore the altered H3K4me3 levels in non-neural tissue of DYT-KMT2B patients.

METHODS:

A database analysis was performed to determine in which parts of the body and in which cells KMT2B is highly expressed. Twelve clinically and genetically diagnosed patients with DYT-KMT2B and 12 control subjects participated in this study. Oral mucosa-derived purified histone proteins were analyzed using Western blotting with anti-H3K4me3 and anti-H4 antibodies.

RESULTS:

Higher expression of KMT2B was observed in oral keratinocytes and gingival fibroblasts, constituting the oral mucosa. In oral mucosa analyses, DYT-KMT2B cases exhibited markedly reduced H3K4me3 levels compared with the controls. Using a cutoff window of 0.90-0.98, the H3K4me3/H4 expression ratio was able to distinguish patient groups.

CONCLUSIONS:

Oral mucosa H3K4me3 analysis is currently not sufficient as a diagnostic tool for DYT-KMT2B, but has the advantage for screening test since it is a non-invasive means.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Histones / Histone-Lysine N-Methyltransferase / Dystonic Disorders / Mouth Mucosa Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Histones / Histone-Lysine N-Methyltransferase / Dystonic Disorders / Mouth Mucosa Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Year: 2024 Type: Article